AA Signature: Revolutionizing Aesthetic Treatment Planning

In the ever-evolving landscape of aesthetic medicine, Allergan Aesthetics, an AbbVie company, has unveiled the AA Signature program, an innovative approach to treatment planning that focuses on patient outcomes. This new initiative, set to launch internationally at the IMCAS World Congress 2025, aims to address the growing demand for personalized, patient-centric aesthetic solutions by harnessing the power of Allergan Aesthetics' advanced product portfolio.



The AA Signature program is rooted in compelling research demonstrating the benefits of holistic treatments. Clinics utilizing treatment plans addressing multiple areas of the face see a 68% higher retention rate compared to those that focus on one area per treatment (Source: Research demonstrating the benefits of holistic treatments). By integrating Allergan Aesthetics' advanced facial portfolio, the AA Signature program empowers healthcare professionals (HCPs) to deliver holistic, personalized treatment plans that maximize patient satisfaction and loyalty.

The program focuses on key patient needs frequently seen in clinical practice, such as lift, definition, and skin quality. These areas are addressed through a combination of products and treatments, tailored to each patient's unique aesthetic goals. For instance, patients seeking a lifted and more defined appearance can benefit from a combination of products targeting lift, definition, and skin quality.

As the Allergan Aesthetics portfolio continues to expand, the AA Signature approach supports HCPs in leveraging new trends, products, and indications to treat different areas of the face. This ensures that patients have access to the most innovative and effective treatment options available. The program offers HCPs cutting-edge training and tools to meet the demands of an increasingly diverse aesthetic environment, ensuring they are equipped to deliver the best possible natural-looking results.

The AA Signature program addresses the rising demand for a holistic treatment approach and leverages Allergan Aesthetics' advanced product portfolio to provide HCPs with access to expert opinions, business support, and comprehensive educational programs. These programs include consumer-focused and AMI-led provider training, ensuring that treatment plans align with individual patient aesthetic goals.

In conclusion, the AA Signature program represents a significant step forward in aesthetic treatment planning, focusing on patient outcomes and addressing the growing demand for personalized, patient-centric solutions. By harnessing the power of Allergan Aesthetics' advanced product portfolio and empowering HCPs with cutting-edge training and tools, the program aims to maximize patient satisfaction and loyalty in the ever-evolving world of aesthetic medicine.